v3.26.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash $ 1,963,796 $ 1,960
Prepaid expenses 50,030 28,600
Prepaid insurance – short-term 107,231
Total Current Assets 2,121,057 30,560
Deferred offering costs 330,108
Prepaid insurance – long-term 62,552
Marketable securities held in Trust Account 103,303,859
TOTAL ASSETS 105,487,468 360,668
Current liabilities    
Accrued expenses 256,669 12,000
Accrued offering costs 287,500
Total Current Liabilities 256,669 385,170
Deferred underwriting fee 3,563,805
Total Liabilities 3,820,474 385,170
Commitments and Contingencies (Note 6)
Class A ordinary shares subject to possible redemption, $0.0001 par value; 10,182,300 shares at redemption value of $10.14 and $0 per share as of June 30, 2026 and December 31, 2025, respectively 103,229,816
Shareholders’ Deficit    
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of June 30, 2026 and December 31, 2025
Additional paid-in capital 370,617
Accumulated deficit (1,563,189) (395,502)
Total Shareholders’ Deficit (1,562,822) (24,502) [1]
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit 105,487,468 360,668
Common Class A [Member]    
Shareholders’ Deficit    
Ordinary shares value 28
Common Class B [Member]    
Shareholders’ Deficit    
Ordinary shares value [2] 339 383
Related Party [Member]    
Current liabilities    
Promissory note – related party $ 85,670
[1] Includes 500,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. As a result of the partial exercise by the underwriters of the over-allotment option on February 12, 2026, 60,767 founder shares were no longer subject to forfeiture. On March 14, 2026, the underwriters’ over-allotment option expired, resulting in 439,233 founder shares being forfeited by the Sponsor for no consideration (Note 7).
[2] Included 500,000 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. As a result of the partial exercise by the underwriters of the over-allotment option on February 12, 2026, 60,767 founder shares were no longer subject to forfeiture. On March 14, 2026, the underwriters’ over-allotment option expired, resulting in 439,233 founder shares being forfeited to the Company (Note 7).